JNL: Jun NH2-terminal kinase
In ITT analysis the GLP-1 RA vs DPP-4 inhibitor cohort median follow-up was 2 years [14] for GLP-1 RAs users and 4 years [27] for DPP-4 inhibitor users
The Company leverages a vertically integrated, proprietary digital care platform, a 50-state affiliated medical group, a state-of-the-art affiliated compounding pharmacy, and a U.S.-based patient care center to expand access to high-quality, affordable care
Wegovy Access & Monitoring Lose meaningful weight with Wegovy, a once-weekly FDA-approved GLP-1 injection shown to help adults lose 30+ lbs on average, quiet food noise, and lessen cravings
At Restore, we use the highest quality nutrients, providing 100% bioavailability of nutrients in the bloodstream as compared to 15-20% from oral supplements